CYTK: Cytokinetics Incorporated
CYTK exchange rate has changed by -2.86% for today. During the day, the instrument was traded at a low of 59.6550 and at a high of 61.3800.
Follow Cytokinetics Incorporated dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CYTK News
- UBS raises Cytokinetics stock price target to $69 on nHCM outlook
- Callos, Cytokinetics EVP, sells $1.6 million in CYTK stock
- BofA raises Cytokinetics stock price target to $67 on Myqorzo
- CYTK Posts a Wider-Than-Expected Q4 Loss, Advances Myqorzo Launch Plans
- Needham raises Cytokinetics stock price target to $85 on trial outlook
- Citizens raises Cytokinetics stock price target to $96 on launch progress
- Cytokinetics, Incorporated (CYTK) Q4 2025 Earnings Call Transcript
- Cytokinetics (CYTK) Reports Q4 Loss, Beats Revenue Estimates
- Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
- Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Cytokinetics Wins EU Approval for Cardiovascular Drug Myqorzo
- Earnings Preview: Cytokinetics (CYTK) Q4 Earnings Expected to Decline
- Can BMY's Growth Portfolio Counter Legacy Drugs Decline in 2026?
- Bayer's Asundexian Shows 26% Stroke Reduction in Late-Stage Study
- Bristol Myers Expects Sales To Decline This Year; So Why Is The Stock Rising?
- Cytokinetics stock maintains Buy rating at B.Riley amid strong CMI market
- Top Biotech Stocks to Watch in 2026, According to Truist
- Regeneron (REGN) Q4 Earnings and Revenues Beat Estimates
Frequently Asked Questions
What is CYTK stock price today?
Cytokinetics Incorporated stock is priced at 60.4100 today. It trades within 59.6550 - 61.3800, yesterday's close was 62.1900, and trading volume reached 4139. The live price chart of CYTK shows these updates.
Does Cytokinetics Incorporated stock pay dividends?
Cytokinetics Incorporated is currently valued at 60.4100. Dividend policy depends on the company, while investors also watch 3.98% and USD. View the chart live to track CYTK movements.
How to buy CYTK stock?
You can buy Cytokinetics Incorporated shares at the current price of 60.4100. Orders are usually placed near 60.4100 or 60.4130, while 4139 and -1.58% show market activity. Follow CYTK updates on the live chart today.
How to invest into CYTK stock?
Investing in Cytokinetics Incorporated involves considering the yearly range 57.8300 - 70.9800 and current price 60.4100. Many compare -1.96% and 3.98% before placing orders at 60.4100 or 60.4130. Explore the CYTK price chart live with daily changes.
What are Cytokinetics Incorporated stock highest prices?
The highest price of Cytokinetics Incorporated in the past year was 70.9800. Within 57.8300 - 70.9800, the stock fluctuated notably, and comparing with 62.1900 helps spot resistance levels. Track Cytokinetics Incorporated performance using the live chart.
What are Cytokinetics Incorporated stock lowest prices?
The lowest price of Cytokinetics Incorporated (CYTK) over the year was 57.8300. Comparing it with the current 60.4100 and 57.8300 - 70.9800 shows potential long-term entry points. Watch CYTK moves on the chart live for more details.
When did CYTK stock split?
Cytokinetics Incorporated has gone through stock splits historically. These changes are visible in , 62.1900, and 3.98% after corporate actions.
- Previous Close
- 62.1900
- Open
- 61.3800
- Bid
- 60.4100
- Ask
- 60.4130
- Low
- 59.6550
- High
- 61.3800
- Volume
- 4.139 K
- Daily Change
- -2.86%
- Month Change
- -1.96%
- 6 Months Change
- 3.98%
- Year Change
- 3.98%